Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 5/20 | 0.83 |
| ▸ | AVPR2 | P30518 | 4/20 | 0.83 |
| ▸ | AVPR1B | P47901 | 2/20 | 0.83 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.83 |
| ▸ | HTR1A | P08908 | 1/20 | 0.83 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.83 |
| ▸ | OXTR | P30559 | 1/20 | 0.83 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.83 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.83 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7355245 | 0.91 | AVPR1A (0.70) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| SCHEMBL7353668 | 0.91 | AVPR1A (0.80) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| Mozavaptan SCHEMBL29388889 | 0.91 | AVPR1A (1.00) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| Mozavaptan SCHEMBL15084884 | 0.91 | AVPR1A (1.00) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| Mozavaptan SCHEMBL1649322 | 0.91 | AVPR1A (1.00) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| SCHEMBL7348322 | 0.91 | AVPR1A (0.77) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| SCHEMBL7353026 | 0.91 | AVPR1A (0.79) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| SCHEMBL7346631 | 0.91 | AVPR1A (0.79) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| SCHEMBL7352805 | 0.91 | AVPR1A (0.79) | AVPR1AAVPR2AVPR1BABCB11HTR1A | |
| SCHEMBL7345958 | 0.91 | AVPR1A (0.79) | AVPR1AAVPR2AVPR1BABCB11HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9132087-B2 | Auris formulations for treating otic diseases and conditions | OTONOMY, INC. (US) | 2015-09-15 | — | — | US | disclosed |
| US-6410573-B1 | CARDIOVASCULAR DISEASES; POTASSIUM CHANNEL MODULATOR | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-06-25 | — | — | US | disclosed |
| US-5985869-A | USEFUL AS VASODILATORS, HYPOTENSIVE AGENTS, WATER DIURETICS, PLATELET AGGLUTINATION INHIBITORS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1999-11-16 | — | — | US | disclosed |
| US-5753677-A | Benzoheterocyclic compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-05-19 | — | — | US | disclosed |
| US-5559230-A | VASOPRESSIN ANTAGONISTS, QUINOLINES, BENZAZEPINES, VASODILATION, HYPOTENSIVE AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-09-24 | — | — | US | disclosed |
| EP-0450097-B1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1996-04-24 | — | — | EP | disclosed |
| WO-1991005549-A1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | WO | disclosed |